Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31,969,743
-$673,996 QoQ
Shares Held
125,880
-5.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.40%
of 13F equity value
Holder Rank
#570
of 4,664 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDGAR LOMAX CO/VA holds $161,967,278 across 7 Drug Manufacturers - General names. JNJ ranks #2 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
1,365,777 | $32,887,910 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
125,880 | $31,969,743 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
461,275 | $26,578,665 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
147,640 | $18,652,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
143,985 | $18,502,072 | |
| 6 | AMGN |
Amgen Inc
|
46,233 | $16,741,893 | |
| 7 | ABBV |
AbbVie Inc.
|
66,103 | $16,634,158 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,969,743 | 125,880 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $32,643,739 | 133,545 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $35,594,365 | 171,995 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $62,694,210 | 338,120 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $67,076,343 | 439,125 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $74,013,562 | 446,295 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $54,860,150 | 379,340 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $33,163,958 | 204,640 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $30,377,894 | 207,840 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,295,040 | 210,475 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,339,673 | 97,867 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $15,931,200 | 102,287 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,239,239 | 104,152 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $16,363,350 | 105,570 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,778,773 | 168,575 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $27,693,604 | 169,525 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $30,261,017 | 170,475 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $29,375,872 | 165,750 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $37,909,112 | 221,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $36,114,630 | 223,620 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $37,202,410 | 225,825 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $38,104,547 | 231,850 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||